+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review

  • ID: 4278837
  • SWOT Analysis
  • October 2020
  • 37 pages
  • GlobalData


  • Acorda Therapeutics Inc
  • Oral Hammaslaakarit Oyj
  • Raisio plc
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Oriola-KD Oyj (Oriola-KD) is a retail and wholesale company which distributes pharmaceuticals, health and wellbeing products. The company provides wide service offerings covering pharmaceutical distribution, branded products and other tailored services to healthcare operators. Its product portfolio includes vitamins, pharmaceutical cosmetics, skincare products, tests, dietary supplements, sports drinks, wound care products and other related products under Avene, Gefilus, Lysi and Oriola’s brands. The company also provides pharmaceutical distribution services and a range of value adding services from clinical research to consumer services to pharmacies, pharma companies, veterinarians and grocery stores. Oriola-KD is headquartered in Espoo, Finland.

Oriola-KD Oyj Key Recent Developments

Jul 17, 2019: Oriola Half Year Financial Report 1 January-30 June 2019
Apr 26, 2019: Oriola Corporation’s interim report January 1- March 31, 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown


  • Acorda Therapeutics Inc
  • Oral Hammaslaakarit Oyj
  • Raisio plc
  • MORE
Section 1 - About the Company
  • Oriola-KD Oyj - Key Facts
  • Oriola-KD Oyj - Key Employees
  • Oriola-KD Oyj - Key Employee Biographies
  • Oriola-KD Oyj - Major Products and Services
  • Oriola-KD Oyj - History
  • Oriola-KD Oyj - Company Statement
  • Oriola-KD Oyj - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Oriola-KD Oyj - Business Description
  • Business Segment: Consumer
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Pharma
  • Overview
  • Performance
  • Business Segment: Retail
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Finland
  • Performance
  • Geographical Segment: Other Countries
  • Performance
  • Geographical Segment: Sweden
  • Performance
  • Oriola-KD Oyj - Corporate Strategy
  • Oriola-KD Oyj - SWOT Analysis
  • SWOT Analysis - Overview
  • Oriola-KD Oyj - Strengths
  • Oriola-KD Oyj - Weaknesses
  • Oriola-KD Oyj - Opportunities
  • Oriola-KD Oyj - Threats
  • Oriola-KD Oyj - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
  • Jul 17, 2019: Oriola Half Year Financial Report 1 January-30 June 2019
  • Apr 26, 2019: Oriola Corporation’s interim report January 1- March 31, 2019
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • Oriola-KD Oyj, Key Facts
  • Oriola-KD Oyj, Key Employees
  • Oriola-KD Oyj, Key Employee Biographies
  • Oriola-KD Oyj, Major Products and Services
  • Oriola-KD Oyj, History
  • Oriola-KD Oyj, Subsidiaries
  • Oriola-KD Oyj, Key Competitors
  • Oriola-KD Oyj, Ratios based on current share price
  • Oriola-KD Oyj, Annual Ratios
  • Oriola-KD Oyj, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Oriola-KD Oyj, Performance Chart (2015 - 2019)
  • Oriola-KD Oyj, Ratio Charts
Note: Product cover images may vary from those shown


  • Raisio plc
  • Oral Hammaslaakarit Oyj
  • Acorda Therapeutics Inc
Note: Product cover images may vary from those shown